Yafei Z. Wang

Department Of Head And Neck Oncology
Tianjin, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 121 publications

ASO Visual Abstract: Association of Preoperative Ultrasound-Measured Tumor Proximity to Trachea and Posterior Capsule with Tracheal and RLN Invasion in Papillary Thyroid Microcarcinoma.

ASO Visual Abstract: Association of Preoperative Ultrasound-Measured Tumor Proximity to Trachea and Posterior Capsule with Tracheal and RLN Invasion in Papillary Thyroid Microcarcinoma.

Journal: Annals of surgical oncology

Published: July 21, 2026

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.

Mezigdomide, carfilzomib, and dexamethasone versus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma (SUCCESSOR-2): a phase 3, open-label, randomised controlled trial.

Journal: Lancet (London, England)

Published: April 29, 2026

Association of Preoperative Ultrasound-Measured Tumor Proximity to Trachea and Posterior Capsule with Tracheal and RLN Invasion in Papillary Thyroid Microcarcinoma.

Association of Preoperative Ultrasound-Measured Tumor Proximity to Trachea and Posterior Capsule with Tracheal and RLN Invasion in Papillary Thyroid Microcarcinoma.

Journal: Annals of surgical oncology

Published: April 06, 2026

Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT.

Identification of immune reconstitution and hematopoiesis restoration by scRNA-seq in bone marrow of multiple myeloma patients treated with high-dose melphalan following auto-HSCT.

Journal: Cancer biology & medicine

Published: March 02, 2026

CAV2 Modulates Cetuximab Sensitivity in HNSCC via Ubiquitin-Mediated Disruption of the PACT-PKR Axis.

CAV2 Modulates Cetuximab Sensitivity in HNSCC via Ubiquitin-Mediated Disruption of the PACT-PKR Axis.

Journal: Cancers

Published: February 28, 2026

Clinical presentation and treatment of plasmablastic myeloma-a multicenter retrospective analysis.

Clinical presentation and treatment of plasmablastic myeloma-a multicenter retrospective analysis.

Journal: Discover oncology

Published: January 21, 2026

Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.

Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.

Journal: Signal transduction and targeted therapy

Published: December 23, 2025

Treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with multiple myeloma: longer follow-up of the real-world MMY4032 study.

Treatment patterns, effectiveness, and safety of daratumumab-based regimens in Chinese patients with multiple myeloma: longer follow-up of the real-world MMY4032 study.

Journal: Annals of hematology

Published: December 15, 2025

Preoperative prediction of Ki-67 expression and prognosis in breast cancer based on contrast-enhanced cone-beam breast CT: a two-centre study.

Preoperative prediction of Ki-67 expression and prognosis in breast cancer based on contrast-enhanced cone-beam breast CT: a two-centre study.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society

Published: October 26, 2025

Longitudinal contrast-enhanced cone beam breast computed tomography for monitoring treatment response in breast cancer neoadjuvant therapy: a comprehensive assessment.

Longitudinal contrast-enhanced cone beam breast computed tomography for monitoring treatment response in breast cancer neoadjuvant therapy: a comprehensive assessment.

Journal: Breast cancer research : BCR

Published: August 27, 2025

Silicon uptake via the transporters SySIT-L and SyLsi-L enhances the growth and photosynthesis of Synechococcus sp. PCC 7002.

Silicon uptake via the transporters SySIT-L and SyLsi-L enhances the growth and photosynthesis of Synechococcus sp. PCC 7002.

Journal: mBio

Published: August 25, 2025

Synechococcus sp. PCC 7002 Performs Anoxygenic Photosynthesis and Deploys Divergent Strategies to Cope with H2Sn and H2O2.

Synechococcus sp. PCC 7002 Performs Anoxygenic Photosynthesis and Deploys Divergent Strategies to Cope with H2Sn and H2O2.

Journal: Antioxidants (Basel, Switzerland)

Published: August 20, 2025

Showing 1-12 of 121

Last Updated: 09/26/2026